Lekooporność – epidemiologia, mechanizmy i znaczenie w leczeniu padaczki

21.09.2021
Pharmacoresistance – Epidemiology, mechanisms, and impact on epilepsy treatment
Mubeen Janmohamed1, Martin J. Brodie2, Patrick Kwan1,3
1 Department of Neuroscience, Alfred Hospital, Central Clinical School, Monash University, Melbourne, Victoria, Australia;
2 University of Glasgow, Glasgow, Szkocja, Wielka Brytania; 3 Departments of Medicine and Neurology, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia
Neuropharmacology 2020; 168: 107790